INTRODUCTION

On 23 and 24 March, the 1st EBF Cyberconnect Event of 2021 will be a Training Day on managing the Practical Aspects of Immunogenicity.  With experience increasing in industry and with regulators, and considering the rapidly growing regulatory requirements, the EBF wants to provide practical tools to help manage the daily challenges and provide value added scientific solutions for  immunogenicity questions coming to the bioanalytical lab.

AIM OF THE WORKSHOP

The training day will focus on 3 important aspects of immunogenicity testing in the bioanalytical laboratory:

• Technology and application
• Regulatory requirements translated into day-to-day practice
• Interpretation of data and totality of data

For all 3, we plan to include plenary/breakouts on case studies aiming at problem solving and/or examples on value, risk and cost considerations of alternative approaches

CALL FOR SPEAKERS

For this Training Day, we will not be issuing a formal call for speakers.

However, if you feel your expertise can contribute to the agenda, please let us know via focus@e-b-f.eu with a short resume of your anticipated contribution. Any contributions with potential business development aspirations will not be considered. Inclusion into the program will be evaluated by the organising committee and is based on its fit with the meeting goals.

MEETING AGENDA

The program of the meeting will become available on the meeting website in the coming weeks

For your calendar planning, the meeting will be from 12:30 CET – 17:30 CET on both 23 and 24 March, i.e. 2 half days, trying to (reasonably) favour America and Asia time zones)

Each session will include a combination of plenary presentations, case studies and Q&A moments

The meeting will be running on the Zoom platform. Based on the positive experience from our recent cybermeetings, we plan to include smaller breakouts to increase interactive discussions and learning opportunities.

WHO SHOULD ATTEND?

Scientists and managers from Pharma R&D, CRO and Health Authorities involved in the bioanalytical challenges of Immunogenicity testing.

CALL FOR REGISTRATION

Web-registration (full registration fee of 235 Euro) opens on 15DEC2020.

The meeting attendance is capped to 100 delegates, with a maximum of 3 delegates/organisation

To register: use this link

Meeting Organisation

Organising Committee: Michaela Golob (Nuvisan), Joanne Goodman (AstraZeneca), Robert Nelson (Covance), Kyra Cowan (Merck KGaA), Roland Staack (Roche) and Philip Timmerman (EBF)